IMRIS Inc.

Delisted

CIK 1489161fmd_1PHFZCEXE50W50YMF72ZKZ2T6MManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Dec 31, 2014, 11 periods

Income Statement · Annual · Millions · USD
Line item	FY2010	FY2011	FY2012	FY2013	FY2014
Total revenues	70	52	52	46	29
Cost of revenue	40	34	35	30	19
Gross profit	31	18	18	16	10
Research and development	6	10	15	18	7
Selling, general and administrative	16	18	18	22	14
Total operating expenses	32	38	45	55	33
Operating income	(1)	(21)	(28)	(39)	(23)
Interest expense	–	–	0	1	5
Interest and investment income	0	0	(0)	(1)	–
Other non-operating income (expense)	(1)	0	(0)	(3)	(7)
Income before taxes	(2)	(21)	(28)	(42)	(30)
Income tax expense	–	0	0	0	0
Net income from continuing operations	–	(21)	(28)	(42)	(30)
Net income	(2)	(21)	(28)	(42)	(30)